The therapeutic mRNA encoded functional Factor VIII (FVIII), aiming to restore protein expression in hemophilia A, a genetic disorder caused by mutations or deficiencies in the F8 gene that results in the absence or dysfunction of FVIII protein [107]. This evidence concerns the gene F8 and hereditary disease.